We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$88.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$80.1M
3
FRPT icon
Freshpet
FRPT
+$60.8M
4
AMZN icon
Amazon
AMZN
+$55.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLJ icon
401
RLJ Lodging Trust
RLJ
$1.69B
– –
-250,000
Closed -$2.93M
RVPH
402
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
– –
-88,200
Closed -$9.08M
SBFM
403
Sunshine Biopharma
SBFM
$2.93M
– –
-107
Closed -$578K
SG icon
404
Sweetgreen
SG
$642M
– –
-125,000
Closed -$1.41M
SHW icon
405
Sherwin-Williams
SHW
$89.8B
– –
-771
Closed -$240K
SIG icon
406
Signet Jewelers
SIG
$3.76B
– –
-20,000
Closed -$2.15M
SLM icon
407
SLM Corp
SLM
$5.15B
– –
-10,363
Closed -$198K
SLS icon
408
SELLAS Life Sciences
SLS
$2.36B
– –
-820,000
Closed -$869K
SOFI icon
409
SoFi Technologies
SOFI
$23.7B
– –
-18,594
Closed -$185K
SPCB icon
410
SuperCom
SPCB
$71.6M
– –
-120,000
Closed -$927K
SRAD icon
411
Sportradar
SRAD
$3.85B
– –
-18,034
Closed -$199K
SYBX
412
DELISTED
Synlogic
SYBX
– –
-1,055,000
Closed -$4.06M
UBX
413
DELISTED
Unity Biotechnology
UBX
– –
-688,000
Closed -$1.33M
UNH icon
414
UnitedHealth
UNH
$370B
– –
-50,000
Closed -$26.3M
VRAX icon
415
Virax Biolabs
VRAX
$2.38M
– –
-4,880
Closed -$178K
VZ icon
416
Verizon
VZ
$196B
– –
-5,825
Closed -$220K
WH icon
417
Wyndham Hotels & Resorts
WH
$5.48B
– –
-120,000
Closed -$9.65M
WYNN icon
418
Wynn Resorts
WYNN
$10.6B
– –
-105,155
Closed -$9.58M
XFOR icon
419
X4 Pharmaceuticals
XFOR
$438M
– –
-64,533
Closed -$1.62M
ZVRA icon
420
Zevra Therapeutics
ZVRA
$686M
– –
-268,000
Closed -$1.76M
SPRB
421
Spruce Biosciences
SPRB
$129M
– –
-29,733
Closed -$6.53M
TCBPW
422
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
– –
-1,882,352
Closed -$61
DBGIW
423
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
– –
-722,890
Closed -$2.2K
FREE
424
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
– –
-2,150,000
Closed -$7.33M
MOR
425
CALL
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
-1,000,000
Closed -$9.9M
14 15 16
17
18

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.